Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER_GOV × Brain Neoplasms × Clear all

Phase

Phase NA 14 Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 88 INDUSTRY 44 NIH 33 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 8 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Multiple Myeloma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Parasomnias 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 HIV Infections 2 Fatigue 2 Erectile Dysfunction 2 Carcinoma, Hepatocellular 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Untreated Advanced Non-small Cell Lung Cancer 1 Thrombocytopenia 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02050243 2014-01-30

5-ALA

Tel-Aviv Sourasky Medical Center

Phase 1/2 Unknown

Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡